Application of velocity loss thresholds during free-weight resistance training: Responses and reproducibility of perceptual, metabolic, and neuromuscular outcomes.
Jonathon J S WeakleyShaun McLarenCarlos Ramirez-LopezAmador García RamosNicholas Dalton BarronHarry BanyardBryan MannDan WeavingBen JonesPublished in: Journal of sports sciences (2019)
The aim of this study was to investigate the differences and long-term reliability in perceptual, metabolic, and neuromuscular responses to velocity loss resistance training protocols. Using a repeated, counterbalanced, crossover design, twelve team-sport athletes completed 5-sets of barbell back-squats at a load corresponding to a mean concentric velocity of ~0.70 m·s-1. On different days, repetitions were performed until a 10%, 20% or 30% velocity loss was attained, with outcome measures collected after each set. Sessions were repeated after four-weeks. There were substantial between-protocol differences in post-set differential ratings of perceived exertion (dRPE, i.e., breathlessness and leg muscles, AU) and blood lactate concentration (B[La], mmol·L-1), such that 30%>20%>10% by small to large magnitudes. Differences in post-set countermovement jump (CMJ) variables were small for most variables, such that 30%<20%<10%. Standard deviations representing four-week variability of post-set responses to each protocol were: dRPE, 8-11; B[La], 0.8-1.0; CMJ height, 1.6-2.0; CMJ PPO, 1.0-1.8; CMJ PCV, 0.04-0.06; CMJ 100ms-Impulse, 5.7-11.9. Velocity loss thresholds control the magnitude of perceptual, metabolic, and neuromuscular responses to resistance training. For practitioners wanting to reliably prescribe training that can induce a given perceptual, metabolic, or neuromuscular response, it is strongly advised that velocity-based thresholds are implemented.
Keyphrases
- resistance training
- body composition
- blood flow
- high intensity
- working memory
- body mass index
- randomized controlled trial
- physical activity
- mental health
- depressive symptoms
- type diabetes
- gold nanoparticles
- palliative care
- skeletal muscle
- weight loss
- quality improvement
- open label
- ms ms
- metabolic syndrome
- clinical trial
- study protocol
- glycemic control
- quantum dots
- weight gain
- general practice
- preterm birth